The result reported by Chatterjee and co-workers found that TGF-β up-regulated PD-L1 on EVs from breast cancer cells that participated in CD8 T-cell dysfunction by weakening phosphorylation of T-cell receptor (TCR) signaling [65]. This evidence concerns the gene CD274 and breast cancer.